# Dual Antiplatelet Therapy Tailored on the Extent of Platelet Inhibition

> **NCT00774475** · PHASE3 · UNKNOWN · sponsor: **University of Florence** · enrollment: 442 (estimated)

## Conditions studied

- Unstable Angina
- NSTEMI

## Interventions

- **DRUG:** comparison of different dosage of clopidogrel
- **DRUG:** doubled therapy

## Key facts

- **NCT ID:** NCT00774475
- **Lead sponsor:** University of Florence
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-11
- **Primary completion:** 2010-11
- **Final completion:** 2011-01
- **Target enrollment:** 442 (ESTIMATED)
- **Last updated:** 2008-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00774475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00774475, "Dual Antiplatelet Therapy Tailored on the Extent of Platelet Inhibition". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00774475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*